Year-over-year earnings per share growth for the last twelve months: Ainos, Inc. (AIMD)

Graphic logo of ainos.com (AIMD)

Ainos, Inc. (AIMD) minimizes diagnostic risks through home testing and remote monitoring, as evidenced by the quarterly EPS trend illustrated in this chart from GURU.Markets. The value of 36.30 represents the current metric. While optimizing express diagnostic logistics improves network margins, the lack of mass chip sales during the research phase temporarily limits the company's operating leverage.

ainos.com (AIMD) - Quarterly EPS earnings growth from 04/28/2023 to 11/16/2026

Comprehensive metric breakdowns and analytics for ainos.com (AIMD)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Ainos, Inc.
Manufactured product of Ainos, Inc.

Investors utilize this indicator as the primary marker of capital management efficiency and the business's ability to generate real earnings per share. The mathematical calculation of the quarterly EPS trend reflects net income growth rates, which for Ainos, Inc. (AIMD) correlates directly with the successful implementation of AI express diagnostic platforms and the effectiveness of protecting their intellectual algorithms.

Competitors of Ainos, Inc. (AIMD)

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OPKO Health|CDNA: Quarterly EPS earnings growth|Maravai LifeSciences Corp (MRVI) - Quarterly EPS earnings growth|FLGT (fulgentgenetics.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Standard BioTools Corp|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth XGN (exagen.com)|MDxHealth Inc. - Year-over-year earnings per share growth for the last twelve months|Lucid Diagnostics, Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Prenetics Global Limited PRE|Insight Molecular (IMDX) - Year-over-year earnings per share growth for the last twelve months|TRIB (Trinity Biotech PLC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months ProPhase Labs|Co-Diagnostics Corp (CODX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HSCS (Heart Test Laboratories Inc.)|Year-over-year net earnings per share change for the last twelve months Biomerica Inc|Year-over-year earnings per share growth for the last twelve months cardiodiagnosticsinc.com CDIO|ONCO: Year-over-year earnings per share growth for the last 12 months|VRAX - Year-over-year earnings per share growth for the last twelve months|BJDX (Bluejay Diagnostics Inc) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months